Hims & Hers Health (HIMS) Inventory Average (2021 - 2026)
Hims & Hers Health (HIMS) reported Inventory Average of $79.6 million for Q1 2026, up 13.29% on a YoY basis from $70.3 million in Q1 2025, and down 14.46% sequentially from $93.1 million in Q4 2025.
Hims & Hers Health (HIMS) Inventory Average (2021 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 6 years of Inventory Average data on file, last reported at $79.6 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory Average rose 13.29% year-over-year to $79.6 million; the trailing twelve-month figure through Mar 2026 stood at $79.6 million (up 13.29% YoY), and the FY2025 full-year result was $72.3 million, up 66.36% from the prior year.
- Inventory Average slipped to $79.6 million in Q1 2026, from $93.1 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $123.9 million in Q3 2025 to a low of $12.9 million in Q1 2022.
- A 5-year average of $46.9 million and a median of $26.1 million in 2024 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average surged 218.63% in 2022 and rose 1.25% in 2023, its largest moves.
- Tracing HIMS's Inventory Average over 5 years: stood at $22.0 million in 2022, then increased by 1.25% to $22.2 million in 2023, then jumped by 155.39% to $56.8 million in 2024, then jumped by 63.93% to $93.1 million in 2025, then dropped by 14.46% to $79.6 million in 2026.
- Business Quant data shows HIMS's Inventory Average at $79.6 million in Q1 2026, $93.1 million in Q4 2025, and $123.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 180.70 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 1.73 Bn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | 79.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.60 Mn |
| Dec 31, 2025 | 93.06 Mn |
| Sep 30, 2025 | 123.89 Mn |
| Jun 30, 2025 | 108.95 Mn |
| Mar 31, 2025 | 70.26 Mn |
| Dec 31, 2024 | 56.77 Mn |
| Sep 30, 2024 | 44.85 Mn |
| Jun 30, 2024 | 35.21 Mn |
| Mar 31, 2024 | 26.15 Mn |
| Dec 31, 2023 | 22.23 Mn |
| Sep 30, 2023 | 21.70 Mn |
| Jun 30, 2023 | 21.06 Mn |
| Mar 31, 2023 | 21.13 Mn |
| Dec 31, 2022 | 21.95 Mn |
| Sep 30, 2022 | 21.01 Mn |
| Jun 30, 2022 | 15.91 Mn |
| Mar 31, 2022 | 12.85 Mn |
| Dec 31, 2021 | 12.21 Mn |
| Sep 30, 2021 | 8.72 Mn |
| Jun 30, 2021 | 5.56 Mn |